Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications ; volume:3 ; number:1 ; day:10 ; month:3 ; year:2016 ; pages:115-120 ; date:3.2016
Drugs - real world outcomes ; 3, Heft 1 (10.3.2016), 115-120, 3.2016
- Creator
-
Hainsworth, John D.
- Contributor
-
Anthony Greco, F.
SpringerLink (Online service)
- DOI
-
10.1007/s40801-016-0064-7
- URN
-
urn:nbn:de:1111-2016033010767
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hainsworth, John D.
- Anthony Greco, F.
- SpringerLink (Online service)
Other Objects (12)
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center